Secondary Logo

Journal Logo

March 2021 - Volume 33 - Issue 3
pp: 309-460


Gastroenterology


Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn’s disease in patients started on antitubercular therapy

Sharma, Vishal; Verma, Suhang; Kumar-M, Praveen; More

European Journal of Gastroenterology & Hepatology. 33(3):334-338, March 2021.

Hepatology


African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians

Satapathy, Sanjaya K.; Marella, Hemnishil K.; Heda, Rajiv P.; More

European Journal of Gastroenterology & Hepatology. 33(3):388-398, March 2021.

De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors

Tejedor-Tejada, Javier; Valenzuela, Esteban Fuentes; Muñoz, Rodrigo Nájera; More

European Journal of Gastroenterology & Hepatology. 33(3):399-406, March 2021.

Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry

Hinrichsen, Holger; Stoehr, Albrecht; Cornberg, Markus; More

European Journal of Gastroenterology & Hepatology. 33(3):415-423, March 2021.

Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease

Zhu, Sheng-Hao; Zheng, Kenneth I.; Hu, Di-Shuang; More

European Journal of Gastroenterology & Hepatology. 33(3):430-435, March 2021.




Show: